In vitro and in vivo performance of supersaturable self-nanoemulsifying system of trans-resveratrol

References

• Almeida L, Vaz-da-Silva M, Falcao A, Soares E, Costa R, Loureiro AI, et al. 2009. Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers. Mol Nutr Food Res. 53:S7–15.
   PubMed Web of Science ®Google Scholar
• Amri A, Chaumeil JC, Sfar S, Charrueau C. 2012. Administration of resveratrol: What formulation solutions to bioavailability limitations. J Control Release. 158:182–193.
   PubMed Web of Science ®Google Scholar
• Amri A, Le Clanche S, Thérond P, Bonnefont-Rousselot D. 2013. Resveratrol self-emulsifying system increases the uptake by endothelial cells and improves protection against oxidative stress-mediated death. Eur J Pharm Biopharm doi:https://doi.org/10.1016/j.ejpb.2013.10.015.
   PubMed Web of Science ®Google Scholar
• Balakrishnan P, Lee BJ, Oh DH. 2009. Enhanced oral bioavailability of dexibuprofen by a novel solid Self-emulsifying drug delivery system (SEDDS). Eur J Pharm Biopharm. 72:539–545.
   PubMed Web of Science ®Google Scholar
• Bandyopadhyay S, Katare OP, Singh B. 2014. Development of optimized supersaturable self-nanoemulsifying systems of ezetimibe: effect of polymers and efflux transporters. Expert Opin Drug Deliv. 11:479–492.
   PubMed Web of Science ®Google Scholar
• Brouwers J, Brewster ME, Augustijns P. 2009. Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability? J Pharm Sci. 98:2549–2572.
   PubMed Web of Science ®Google Scholar
• Elsheikh MA, Elnaggar YSR, Gohar EY, Abdallah OY. 2012. Nanoemulsion liquid preconcentrates for raloxifene hydrochloride: optimization and in vivo appraisal. Int J Nanomedicine. 7:3787–3802.
   PubMed Web of Science ®Google Scholar
• Gao P, Morozowich W. 2006. Development of supersaturatable self-emulsifying drug delivery system formulations for improving the oral absorption of poorly soluble drugs. Expert Opin Drug Deliv. 3:97–110.
   PubMedGoogle Scholar
• Gao P, Akrami A, Alvarez F, Hu J, Li L, Ma C, Surapaneni S. 2009. Characterization and optimization of AMG 517 supersaturatable selfemulsifying drug delivery system (S-SEDDS) for improved oral absorption. J Pharm Sci. 98:516–528.
   PubMed Web of Science ®Google Scholar
• Hung CF, Chen JK, Liao MH, Lo HM, Fang JY. 2006. Development and evaluation of emulsion-liposome blends for resveratrol delivery. J Nanosci Nanotechnol. 6:2950–2958.
   PubMed Web of Science ®Google Scholar
• Johnson DA, Amidon GL. 1998. Determination of intrinsic membrane transport parameters from perfused intestine experiments: a boundary layer approach to estimating the aqueous and unbiased membrane permeabilities. J Theor Biol. 131:93–106.
   Google Scholar
• Kim S, Na WK, Dong Y, Das S, Tan RBH. 2012. Preparation and physicochemical characterization of trans-resveratrol nanoparticles by temperature-controlled antisolvent precipitation. J Food Eng. 10:37–42.
   Google Scholar
• Marier JF, Vachon P, Gritsas A. 2002. Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model. J Pharmacol Exp Ther. 302:369–373.
   PubMed Web of Science ®Google Scholar
• Nam JB, Ryu JH, Kim JW, Chang IS, Suh KD. 2005. Stabilization of resveratrol immobilized in monodisperse cyano-functionalized porous polymeric microspheres. Polymer. 46:8956–8963.
   Web of Science ®Google Scholar
• Porter CJ, Charman WN. 2001. Intestinal lymphatic drug transport: an update. Adv Drug Deliv Rev. 50:61–80.
   PubMed Web of Science ®Google Scholar
• Singh G, Pai RS. 2014a. Optimized PLGA nanoparticle platform for orally dosed trans-resveratrol 380 with enhanced bioavailability potential. Expert Opin Drug Deliv. 11:647–659.
   PubMed Web of Science ®Google Scholar
• Singh G, Pai RS. 2014b. Trans-resveratrol self nano-emulsifying drug delivery systems 336 (SNEDDS) with enhanced bioavailability potential: Optimization, pharmacokinetics and in situ single pass intestinal perfusion (SPIP) studies. Drug Deliv. doi:https://doi.org/10.3109/10717544.2014.885616.
   Google Scholar
• Singh G, Pai RS. 2014c. Recent advances of resveratrol in nanostructured based delivery systems and in the management of HIV/AIDS. J Control Release. 194:178–188.
   PubMed Web of Science ®Google Scholar
• Singh G, Pai RS, Pandit V. 2014. In vivo pharmacokinetic applicability of a simple and validated HPLC method for orally administered trans-resveratrol loaded polymeric nanoparticles to rats. J Pharm Investig. 44:69–78.
   Google Scholar
• Tadros T. (2009). Polymeric surfactants in disperse systems. Adv Colloid Interface Sci. 147–148:281–299.
   PubMed Web of Science ®Google Scholar
• Thomas N, Holm R, Mullertz A, Rades T. 2012. In vitro and in vivo performance of novel supersaturated self-nanoemulsifying drug delivery systems (super-SNEDDS). J Control Release. 160: 25–32.
   PubMed Web of Science ®Google Scholar
• Troche-Pesqueir E, Perez-Juste I, Navarro-Vazquez A, Cid MM. 2013. A β-cyclodextrin–resveratrol inclusion complex and the role of geometrical and electronic effects on its electronic induced circular dichroism. RSC Adv. 3:10242–10250.
   Web of Science ®Google Scholar
• Wei Y, Ye X, Shang X, Peng X, Bao Q, Liu M, et al. 2012. Enhanced oral bioavailability of silybin by a supersaturatable self-emulsifying drug delivery system (S-SEDDS). Colloids Surf A Physicochem Eng Asp. 396:22–28.
   Web of Science ®Google Scholar
• Wegiel LA, Mauer LJ, Edgar KJ, Taylor LS. 2013. Crystallization of amorphous solid dispersions of resveratrol during preparation and storage-Impact of different polymers. J Pharm Sci. 102:171–184.
   PubMed Web of Science ®Google Scholar